Literature DB >> 17934999

A normative study of the trail making test A and B in Greek adults.

I Zalonis1, E Kararizou, N I Triantafyllou, E Kapaki, S Papageorgiou, P Sgouropoulos, D Vassilopoulos.   

Abstract

The purpose of this study was to explore the effects of age and education on the performance of the Trail Making Test (TMT), and to provide normative data in the Greek population. The TMT was administered to 643 healthy participants. All participants satisfied the criteria excluding dementia and other medical, psychiatric, and neurological disorders. Statistical analysis revealed that, age, education, and general level of intelligence significantly influence individual performance. Performance on TMT, especially part B, decreases with increasing age and lower levels of education. Current norms of the Greek version of TMT represent a useful set of norms for clinical practice.

Entities:  

Mesh:

Year:  2007        PMID: 17934999     DOI: 10.1080/13854040701629301

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  22 in total

1.  Neuropsychological and psychiatric aspects of multiple sclerosis: preliminary investigation of discrete profiles across neurological subtypes.

Authors:  Marina Katsari; Dimitrios Kasselimis; Gerasimos Gasparinatos; Roubina Antonellou; Konstantinos Voumvourakis
Journal:  Neurol Sci       Date:  2016-01-07       Impact factor: 3.307

2.  Trail Making Test error analysis in classic motor neuron disease.

Authors:  Foteini Christidi; Evangelia Kararizou; Nikolaos I Triantafyllou; George P Paraskevas; Ioannis Zalonis
Journal:  Neurol Sci       Date:  2012-11-18       Impact factor: 3.307

3.  Associations between physical performance and executive function in older adults with mild cognitive impairment: gait speed and the timed "up & go" test.

Authors:  Ellen L McGough; Valerie E Kelly; Rebecca G Logsdon; Susan M McCurry; Barbara B Cochrane; Joyce M Engel; Linda Teri
Journal:  Phys Ther       Date:  2011-05-26

4.  In Search of Executive Impairment in Pathological Gambling: A Neuropsychological Study on Non-treatment Seeking Gamblers.

Authors:  Alexandros Kapsomenakis; Panagiotis G Simos; Georgios Konstantakopoulos; Dimitrios S Kasselimis
Journal:  J Gambl Stud       Date:  2018-12

5.  A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia.

Authors:  A Chan; R Remington; E Kotyla; A Lepore; J Zemianek; T B Shea
Journal:  J Nutr Health Aging       Date:  2010-03       Impact factor: 4.075

6.  Cerebral perfusion disturbances in chronic mild traumatic brain injury correlate with psychoemotional outcomes.

Authors:  Efrosini Papadaki; Eleftherios Kavroulakis; Katina Manolitsi; Dimitrios Makrakis; Emmanouil Papastefanakis; Pelagia Tsagaraki; Styliani Papadopoulou; Alexandros Zampetakis; Margarita Malliou; Antonios Vakis; Panagiotis Simos
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

7.  Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study.

Authors:  Quynh T Vo; Christopher Cox; Xiuhong Li; Lisa P Jacobson; Rosemary McKaig; Ned Sacktor; Ola A Selnes; Eileen Martin; James T Becker; Eric N Miller
Journal:  J Neurovirol       Date:  2012-12-11       Impact factor: 2.643

8.  The impact of athrosclerosis on cognition and disability in multiple sclerosis patients: the ATHUS score.

Authors:  A V Valavanis; E Tsitsipa; S Intzes; E Psoma; T Tegos
Journal:  Hippokratia       Date:  2019 Apr-Jun       Impact factor: 0.471

9.  The performance of patients with Parkinson's disease on the Face-Name Associative Memory Examination.

Authors:  Constantinos Kormas; Ioannis Zalonis; Ioannis Evdokimidis; Constantin Potagas
Journal:  Neurol Sci       Date:  2018-09-12       Impact factor: 3.307

10.  The Effects of Aging, Malingering, and Traumatic Brain Injury on Computerized Trail-Making Test Performance.

Authors:  David L Woods; John M Wyma; Timothy J Herron; E William Yund
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.